IRCT20190717044241N3招募中2 期
Cell therapy in patients with COVID-19 using mesenchymal stem cells: Phase 2 clinical trial
Barakat Pharmaceutical Group0 个研究点目标入组 20 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 17 years 至 65 years（—）
- 性别
- All
入选标准
- •Persistent hypoxemia despite receiving less than 93% Saturation oxygen
- •Respiratory failure requires a Ventilator
- •Chest has multilobar infiltrates
排除标准
- •Patient dissatisfaction
- •Pregnant patient
- •Age under 18 years and over 65 years
- •Patient with known active malignancy
- •Organ failure
研究者
相似试验
招募中
1 期
Cell therapy in patients with COVID-19IRCT20190717044241N2Barakat Pharmaceutical Group5
进行中（未招募）
1 期
Therapy with stem cells for Patients with severe COVID-19 infectioPatients with severe COVID-19 infectionMedDRA version: 23.1Level: LLTClassification code 10084401Term: COVID-19 respiratory infectionSystem Organ Class: 100000004862EUCTR2020-002102-58-BECHU de Liège20
尚未招募
不适用
A medical records based study for Tou-Jie-Qu-Wen Granules in the Treatment of mild and moderate patients with novel coronavirus pneumonia (COVID-19)COVID-19ITMCTR2000003144Guangzhou Eighth People's Hospital
尚未招募
不适用
Ozone Therapy for Covid 19 patientsCTRI/2020/07/026671Bisleri charitable trust
招募中
2 期
Treatment of COVID-19-induced cytokine storm by hemoperfusioIRCT20200317046797N5Tabriz University of Medical Sciences10